|

Phentolamine Clinical Trials

1 actively recruiting trial

Also known as: Rogitamine

Pipeline

Phase 2/3: 1

Top Sponsors

  • Helwan University1

Indications

  • Adrenergic Receptor Antagonist Adverse Reaction1
  • CA-AKI - Contrast-Associated Acute Kidney Injury1
  • Heart Disease1
  • Acute Coronary Syndrome1
  • Coronary Artery Disease1

Other1 trial

Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.